Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease

NCT02528617 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT02528617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02528617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease
Lead sponsor
Baylor Research Institute
Phase
Phase 4
Overall status
Withdrawn
Start date
July 31, 2015
Completion date
October 31, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher disease type 1, gaucher disease type 3